Comprehensive analysis of hepatic gene and protein expression profiles on phenobarbital- or clofibrate-induced hepatic hypertrophy in dogs

Journal of Toxicological Sciences

Volumn 34, Issue 6, 2009, Pages 647-661

  Makino, Toshihiko ^a,b   Kinoshita, Junzo ^a   Arakawa, Shingo ^a   Ito, Kazumi ^a   Ando, Yosuke ^a   Yamoto, Takashi ^a   Teranishi, Munehiro ^a   Sanbuissho, Atsushi ^a   Nakayama, Hiroyuki ^b  

^a DAIICHI SANKYO CO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

2 dimension difference gel electrophoresis; Clofibrate; Dog; Liver; Microarray; Phenobarbital

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE II; CLOFIBRATE; CYTOCHROME P450 2B; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 4A; DRUG METABOLIZING ENZYME; PHENOBARBITAL; PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVATE CARBOXYLASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA CHAIN; BIOCHEMISTRY; CONTROLLED STUDY; DOG; ENZYME INDUCTION; GEL ELECTROPHORESIS; GENE EXPRESSION; GENOMICS; HISTOPATHOLOGY; LIVER HYPERTROPHY; MALE; MITOCHONDRIAL GENE; MITOCHONDRION; MORPHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; RISK ASSESSMENT; SMOOTH ENDOPLASMIC RETICULUM; WESTERN BLOTTING;

CANIS FAMILIARIS;

EID: 73849144195     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.647     Document Type: Article

References (44)

1. Amacher, D.E. (2006): A Toxicologist's Guide to the Preclinical Assessment of Hepatic Microsomal Enzyme Induction. Toxicol. Mech. Methods, 16, 385-394.
2. Amacher, D.E., Beck, R., Schomaker, S.J. and Kenny, C.V. (1997): Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of Clofibrate, gemfibrozil, or bezafibrate in the CD rat. Toxicol. Appl. Pharmacol., 142, 143-150.
3. Anderson, L. and Seilhamer, J. (1997): A comparison of selected mRNA and protein abundances in human liver. Electrophoresis, 18, 533-537.
4. Bell, A.R., Savory, R., Horley, N.J., Choudhury, A.I., Dickins, M., Gray, T.J., Salter, A.M. and Bell, D.R. (1998): Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia. Biochem. J., 332, 689-693.
5. Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D. and Wiegand, H.J. (1993): Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol., 31, 857-907.
6. Bock, K.W., Fröhling, W., Remmer, H. and Rexer, B. (1973): Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim. Biophys. Acta., 327, 46-56.
7. Bradford, M.M. (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
8. Burnette, W.N. (1981): "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate - Polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem., 112, 195-203.
9. Celis, J.E., Kruhøffer, M., Gromova, I., Frederiksen, C., Østergaard, M., Thykjaer, T., Gromov, P., Yu, J., Pálsdó ttir, H., Magnusson, N. and Ørntoft, T.F. (2000): Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. FEBS Lett., 480, 2-16.
10. David, R.M., Moore, M.R., Cifone, M.A., Finney, D.C. and Guest, D. (1999): Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol. Sci., 50, 195-205.
11. Desvergne, B. and Wahli, W. (1999): Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev., 20, 649-688.
12. Fruchart, J.C., Brewer, H.B.Jr. and Leitersdorf, E. (1998): Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group. Am. J. Cardiol., 81, 912-917.
13. Galeva, N. and Altermann, M. (2002): Comparison of one-dimensional and two-dimensional gel electrophoresis as a separation tool for proteomic analysis of rat liver microsomes: cytochromes P450 and other membrane proteins. Proteomics, 2, 713-722.
14. Gerhold, D., Rushmore, T. and Caskey, C.T. (1999): DNA chips: promising toys have become powerful tools. Trends Biochem. Sci., 24, 168-173.
15. Gervois, P., Torra, I.P., Chinetti, G., Grötzinger, T., Dubois, G., Fruchart, J.C., Fruchart-Najib, J., Leitersdorf, E. and Staels, B. (1999): A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. Mol. Endocrinol., 13, 1535-1549.
16. Gonzalez, F.J. (2002): The peroxisome proliferator-activated receptor alpha (PPARalpha): role in hepatocarcinogenesis. Mol. Cell. Endocrinol., 193, 71-79.
17. Graham, M.J. and Lake, B.G. (2008): Induction of drug metabolism: species differences and toxicological relevance. Toxicology, 254, 184-191.
18. Graham, R.A., Downey, A., Mudra, D., Krueger, L., Carroll, K., Chengelis, C., Madan, A. and Parkinson, A. (2002): In vivo and in vitro induction of cytochrome P450 enzymes in beagle dogs. Drug Metab. Dispos., 30, 1206-1213.
19. Graham, R.A., Goodwin, B., Merrihew, R.V., Krol, W.L. and Lecluyse, E.L. (2006): Cloning, tissue expression, and regulation of beagle dog CYP4A genes. Toxicol. Sci., 92, 356-367.
20. Gygi, S.P., Rochon, Y., Franza, B.R. and Aebersold, R. (1999): Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol., 19, 1720-1730.
21. Habig, W.H., Pabst, M.J. and Jakoby, W.B. (1974): Glutathione S-transferases. The first enzymatic step in mercapturic acid forma-tion. J. Biol. Chem., 249, 7130-7139.
22. Harmon-Fletcher, M.P. and Barnett, Y.A. (2008): Lymphocyte cytochrome P450 expression: inducibility studies in male Wistar rats. Br. J. Biomed. Sci., 65, 1-6.
23. Hoivik, D.J., Quails, C.W.Jr., Mirabile, R.C., Cariello, N.F., Kimbrough, C.L., Colton, H.M., Anderson, S.P., Santostefano, M.J., Morgan, R.J., Dahl, R.R., Brown, A.R., Zhao, Z., Mudd, P.N.Jr., Oliver, W.B.Jr., Brown, H.R. and Miller, R.T. (2004): Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys. Carcinogenesis, 25, 1757-1769.
24. Hsu, M.H., Savas, U., Griffin, K.J. and Johnson, E.F. (2001): Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells. J. Biol. Chem., 276, 27950-27958.
25. Kane, C.D., Francone, O.L. and Stevens, K.A. (2006): Differential regulation of the cynomolgus, human, and rat acyl-CoA oxidase promoters by PPARalpha. Gene, 380, 84-94.
26. Kelley, M., Groth-Watson, A., Knoble, D. and Kornbrust, D. (1994): Induction of peroxisomal enzymes by a tetrazole-substituted 2-quinolinylmethoxy leukotriene D4 antagonist. Fundam. Appl. Toxicol., 23, 298-303.
27. Lai, D.Y. (2004): Rodent carcinogenicity of peroxisome proliferators and issues on human relevance. J. Environ. Sci. Health. C. Environ. Carcinog. Ecotoxicol. Rev., 22, 37-55.
28. Lake, B.G., Evans, J.G., Gray, T.J., Körösi, S.A. and North, C.J. (1989): Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset. Toxicol. Appl. Pharmacol., 99, 148-160.
29. Léonard, J.F., Courcol, M., Mariet, C., Charbonnier, A., Boitier, E., Duchesne, M., Parker, F., Genet, B., Supatto, F., Roberts, R. and Gautier, J.C. (2006): Proteomic characterization of the effects of Clofibrate on protein expression in rat liver. Proteomics, 6, 1915-1933.
30. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
31. Makino, T., Sehata, S., Igarashi, I., Watanabe, T., Ohashi, Y., Manabe, S. and Yamoto, T. (1998): Induction of glutathione S-transferases and hepatocellular proliferating activities in the rat liver treated with tert-butylated hydroxyanisole, 1,2-bis(2-pyridyl)ethylene, and phenobarbital. J. Toxcol. Pathol., 11, 183-189.
32. Matsubara, T., Otsubo, S., Yoshihara, E. and Touchi, A. (1983): Biotransformation of coumarin derivatives. (2). Oxidative metabolism of 7-alkoxycoumarin by microsomal enzymes and a simple assay procedure for 7-alkoxycoumarin O-dealkylase. Jpn. J. Pharmacol., 33, 41-56.
33. Morimura, K., Cheung, C., Ward, J.M., Reddy, J.K. and Gonzalez, F.J. (2006): Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor α to Wy-14,643-induced liver tumorigenesis. Carcinogenesis, 27, 1074-1080.
34. Omura, T. and Sato, R. (1964): The Carbon Monoxide-Binding Pigment of Liver Microsomes. I. Evidence for Its Hemoprotein Nature. J. Biol. Chem., 239, 2370-2378.
35. Palmer, C.N., Hsu, M.H., Griffin, K.J., Raucy, J.L. and Johnson, E.F. (1998): Peroxisome proliferator activated receptor-alpha expression in human liver. Mol. Pharmacol., 53, 14-22.
36. Petushkova, N.A., Kanaeva, I.P., Lisitsa, A.V., Sheremetyeva, G.F., Zgoda, V.., Samenkova, N.F., Karuzina, II and Archakov, A.I. (2006): Characterization of human liver cytochromes P450 by combining the biochemical and proteomic approaches. Toxicol. In Vitro, 20, 966-974.
37. Quinones, Q.J., de Ridder, G.G. and Pizzo, S.V. (2008): GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum. Histol. Histopathol., 23, 1409-1416.
38. Sameshima, H., Haraguchi, T., Chihaya, Y., Nagata, R., Ohbayashi, S., Mogi, M. and Tsuchiya, T. (1995): Repeated oral dose toxicity study of fenofibrate in beagle dogs for 52 weeks. Jpn. Pharmacol. Ther., 23, S949-972.
39. Sanders, S. and Thorgeirsson, S.S. (1999): Phenobarbital promotes liver growth in c-myc/TGF-alpha transgenic mice by inducing hypertrophy and inhibiting apoptosis. Carcinogenesis, 20, 41-49.
40. Satoh, T. and Hosokawa, M. (2006): Structure, function and regulation of carboxylesterases. Chem. Biol. Interact., 162, 195-211.
41. Takahashi, S., Katoh, M., Saitoh, T., Nakajima, M. and Yokoi, T. (2009): Different inhibitory effects in rat and human carboxylesterases. Drug Metab. Dispos., 37, 956-961.
42. Watanabe, T., Horie, S., Yamada, J., Isaji, M., Nishigaki, T., Naito, J. and Suga, T. (1989): Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes. Biochem. Pharmacol., 38, 367-371.
43. Yang, M.C., Ruan, Q.G., Yang, J.J., Eckenrode, S., Wu, S., McIndoe, R.A. and She, J.X. (2001): A statistical method for flagging weak spots improves normalization and ratio estimates in microarrays. Physiol. Genomics, 7, 45-53.
44. Youssef, J. and Badr, M. (1998): Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease. Crit. Rev. Toxicol., 28, 1-33.